Esposito Pamela bought KYMR
December 17, 2025 · Form 4 insider transaction
Esposito Pamela bought 3,000 shares of Kymera Therapeutics, Inc. at $31.20 per share, a transaction worth $93.6K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,000
Price
$31.20
Total value
$93.6K
InsiderEsposito Pamela
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 17, 2025
Filing dateDecember 17, 2025
Shares owned after27,563
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 17, 2025 adopted by the reporting person.